newsfilter
← Latest News
GlobeNewswire·

Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer Therapy

STAMFORD, Conn., April 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), an artificial intelligence (AI)-driven genomic and clinical data intelligence platform company, and researchers from the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai